Related Post
A new study by King’s College London revealed that the HPV vaccine (HPVHe succeeded in preventing up to 90% of cervical cancer cases before they occur, according to the British Daily Mail website.
The study said that cervical cancer cases have fallen by 87% in Britain as a result of the HPV vaccine program conducted by the British Health Authority. NHS.
Cervical cancer incidence has fallen from 50 cases a year to just five among girls in their twenties – the first generation to get vaccinated, she said. The study’s findings represent the first evidence that the HPV vaccine saves lives.
The HPV vaccine prevents infection with HPV, a common group of viruses that cause 90% of cervical cancer cases.
It has been offered to girls aged 12 and 13 in the UK since 2008, and as of 2019 it is also available to teenage boys.
Men can also get cancer from HPV and can also put women at increased risk by sexually transmitting the virus.
About 3,200 cases of cervical cancer are diagnosed each year in Britain, resulting in more than two deaths a day, but today’s study suggests that the HPV vaccine will essentially eliminate the disease in younger generations, as it will soon become a “disease”. Rarely” and a thing of the past.
The researchers said they expect to eliminate cervical cancer completely within 80 years.
The research, published in The Lancet, found cervical cancer rates were 87% lower in women who got vaccinated between the ages of 12 and 13 compared to those who didn’t.
There was also a 97% reduction in precancerous changes in cells among this age group, or cervical cancer.
For women who got the vaccine between 14 and 16 years old, cervical cancer rates were 62% lower and were one-third lower among women who got it between 16 and 18 years old.
Experts estimated that the first four years of the vaccination program – between 2008 and 2012 – resulted in a decrease of about 450 cases of cervical cancer and 17,200 fewer cases of cervical cancer.
Professor Peter Sasini, senior author of the study, said: ‘It was astonishing to see the impact of the HPV vaccine and now we can prove that it has prevented hundreds of women from developing cancer in England.
Dr Vanessa Saliba, a consultant epidemiologist for the UK’s Health Security Agency, who was also involved in the study, said: “These remarkable results confirm that the HPV vaccine saves lives by significantly reducing cervical cancer rates among women.”
